NovoCure Ltd

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC NVCR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

226,500

Value ($000)

2,929

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,929	0.0%	226,500	12/31/2025
2025 Q3	11/14/2025	15,447	0.0%	1,195,624	9/30/2025
2025 Q2	8/14/2025	24,413	0.0%	1,371,531	6/30/2025
2025 Q1	5/19/2025	31,758	0.0%	1,782,159	3/31/2025
2024 Q4	2/14/2025	20,909	0.0%	701,645	12/31/2024
2024 Q3	11/14/2024	14,192	0.0%	907,999	9/30/2024
2024 Q2	8/14/2024	14,105	0.0%	823,393	6/30/2024
2024 Q1	5/15/2024	2,108	0.0%	134,883	3/31/2024
2023 Q4	2/14/2024	1,924	0.0%	128,872	12/31/2023
2023 Q3	11/13/2023	1,919	0.0%	118,830	9/30/2023
2023 Q2	8/11/2023	25,646	0.0%	426,438	6/30/2023
2023 Q1	5/15/2023	25,646	0.0%	426,438	3/31/2023
2022 Q4	2/14/2023	31,862	0.0%	434,380	12/31/2022
2022 Q3	11/14/2022	30,793	0.0%	405,278	9/30/2022
2022 Q2	8/12/2022	29,942	0.0%	430,820	6/30/2022
2022 Q1	5/16/2022	25,869	0.0%	312,243	3/31/2022
2021 Q4	2/14/2022	24,572	0.0%	327,271	12/31/2021
2021 Q3	11/15/2021	36,566	0.0%	314,761	9/30/2021
2021 Q2	8/16/2021	69,655	0.0%	314,016	6/30/2021
2021 Q1	5/14/2021	37,395	0.0%	282,910	3/31/2021
2020 Q4	3/1/2021	38,463	0.0%	222,279	12/31/2020
2020 Q3	11/13/2020	12,228	0.0%	109,858	9/30/2020
2020 Q2	8/14/2020	5,927	0.0%	99,956	6/30/2020
2020 Q1	5/15/2020	14,754	0.0%	219,104	3/31/2020
2019 Q4	2/14/2020	20,357	0.0%	241,574	12/31/2019